AbstractBackgroundVisceral leishmaniasis (VL) or Kala-Azar (KA) is one of the most deadly forms of disease among all neglected tropical diseases. There are no satisfactory drugs or vaccine candidates available for this dreaded disease. Our previous studies showed promising therapeutic and prophylactic efficacy of the live, radio-attenuated parasites through intramuscular (I.M.) and intraperitoneal (I.P.) route in BALB/c mice model.MethodsThe T-cell proliferation level, the mRNA expression level of inducible nitric oxide synthase (iNOS) and tumor growth factor-beta (TGF-β) genes and finally the phosphorylation levels of phosphoinositide dependent kinase 1 (PDK1), phosphoinositide 3 kinase (PI3K) and p38 mitogen activated protein kinase (p38M...
Visceral leishmaniasis caused by Leishmania donovani is the most severe systemic form of the disease...
Leishmania infantum parasites cause a severe form of visceral leishmaniasis in human and viscerocuta...
Background: Recovery from cutaneous leishmaniasis (CL) leads to protection against further lesion de...
After our promising results from prophylactic and therapeutic study (i.p. route) with the radio-atte...
Visceral leishmaniasis (VL) or Kala azar is caused by the parasite Leishmania donovani. VL is associ...
Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 m...
The present study intends to evaluate the role of radio-attenuated leishmania parasites as immunopro...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
Background Leishmania (L.) species are the causative agent of leishmaniasis. Due to the lack of effi...
AbstractVisceral leishmaniasis is a chronicand lethal parasite disease against which no human vaccin...
Leishmaniasis is the spectrum of diseases that are caused by single cell protozoan parasites of Leis...
BALB/c mice immunized intraperitoneally (i.p.) and intravenously (i.v.) with Leishmania donovani pro...
Experiments described in this paper were aimed at determining whether subcutaneous inoculation of li...
Visceral leishmaniases (VL) or kala-azar is the most dreaded and devastating amongst the various for...
Visceral leishmaniasis is an infectious parasitic disease caused by the protozoan parasites Leishman...
Visceral leishmaniasis caused by Leishmania donovani is the most severe systemic form of the disease...
Leishmania infantum parasites cause a severe form of visceral leishmaniasis in human and viscerocuta...
Background: Recovery from cutaneous leishmaniasis (CL) leads to protection against further lesion de...
After our promising results from prophylactic and therapeutic study (i.p. route) with the radio-atte...
Visceral leishmaniasis (VL) or Kala azar is caused by the parasite Leishmania donovani. VL is associ...
Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 m...
The present study intends to evaluate the role of radio-attenuated leishmania parasites as immunopro...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
Background Leishmania (L.) species are the causative agent of leishmaniasis. Due to the lack of effi...
AbstractVisceral leishmaniasis is a chronicand lethal parasite disease against which no human vaccin...
Leishmaniasis is the spectrum of diseases that are caused by single cell protozoan parasites of Leis...
BALB/c mice immunized intraperitoneally (i.p.) and intravenously (i.v.) with Leishmania donovani pro...
Experiments described in this paper were aimed at determining whether subcutaneous inoculation of li...
Visceral leishmaniases (VL) or kala-azar is the most dreaded and devastating amongst the various for...
Visceral leishmaniasis is an infectious parasitic disease caused by the protozoan parasites Leishman...
Visceral leishmaniasis caused by Leishmania donovani is the most severe systemic form of the disease...
Leishmania infantum parasites cause a severe form of visceral leishmaniasis in human and viscerocuta...
Background: Recovery from cutaneous leishmaniasis (CL) leads to protection against further lesion de...